The authors have no conflicts of interest to declare. A moderate per capita remuneration was received by the institution per completed CRF.
FM and MS prepared the manuscript. All authors contributed to this clinical trial, i.e. study design, study conduct, data collection and review of the manuscript. All authors approved the manuscript prior to submission.
The aim of this study was to compare the 5-year survival and success rates of 3.3 mm dental implants either made from titanium-zirconium (TiZr) alloy or from Grade IV titanium (Ti Grade IV) in mandibular implant-based removable overdentures.
The core study had a follow-up period of 36 months and was designed as a randomized, controlled, double-blind, split-mouth multicenter clinical trial. Patients with edentulous mandibles received two Straumann Bone Level implants (diameter 3.3 mm, SLActive®), one of TiZr (test) and one of Ti Grade IV (control), in the interforaminal region. This follow-up study recruited patients from the core study and evaluated the plaque and sulcus bleeding indices, radiographic crestal bone level, as well as implant survival and success 60 months after implant placement.
Of the 91 patients who initially received implants, 75 completed the 36 month follow-up and 49 were available for the 60 month examination. Two patients were excluded so that a total of 47 patients with an average age of 72 ± 8 years were analysed. The characteristics and 36-month performance of the present study cohort did not differ from the non-included initial participants (p > 0.05). In the period since the 36-month follow-up examination, no implant was lost. The cumulative implant survival rate was 98.9 % for the TiZr group and 97.8 % for the Ti Grade IV group. Crestal bone level changes at 60 months were not different in the test and control group (TiZr −0.60 ± 0.69 mm and Ti Grade IV −0.61 ± 0.83 mm; p = 0.96). The cumulative implant success rate after 60 months was 95.8 and 92.6 % for TiZr and Ti Grade IV, respectively.
After 60 months, the positive outcomes of the 36 month results for TiZr and Ti Grade IV implants were confirmed, with no significant differences with regard to crestal bone level change, clinical parameters and survival or success rates. TiZr implants performed equally well compared to conventional Ti Grade IV 3.3 mm diameter-reduced implants for mandibular removable overdentures.
Registered on www.clinicaltrials.gov: NCT01878331
Hugoson A, Koch G, Gothberg C, Helkimo AN, Lundin SA, Norderyd O, et al. Oral health of individuals aged 3–80 years in Jonkoping, Sweden during 30 years (1973–2003). II. Review of clinical and radiographic findings. Swed Dent J. 2005;29(4):139–55. PubMed
Mojon P. The world without teeth: Demographic Trends. In: Feine J, Carlsson GE, editors. Implant Overdentures, the Standard of Care for Edentulous Patients. Chicago: Quintessence; 2003. p. 3–14.
MacEntee MI, Müller F, Wyatt CC. Oral Healthcare and The Frail Elder: A Clinical Perspective. Ames: Wiley-Blackwell; 2011.
Andreiotelli M, Att W, Strub JR. Prosthodontic complications with implant overdentures: a systematic literature review. Int J Prosthodont. 2010;23(3):195–203. PubMed
Ikarashi Y, Toyoda K, Kobayashi E. Improved Biocompatibility of Titanium-Zirconium (Ti-Zr) Alloy: Tissue Reaction and Sensitization to Ti-Zr Alloy Compared with Pure Ti and Zr in Rat Implantation Study. Mater Trans. 2005;46:2260–7. CrossRef
Al-Nawas B, Bragger U, Meijer HJ, Naert I, Persson R, Perucchi A, et al. A Double-Blind Randomized Controlled Trial (RCT) of Titanium-13Zirconium versus Titanium Grade IV Small-Diameter Bone Level Implants in Edentulous Mandibles - Results from a 1-Year Observation Period. Clin Implant Dent Relat Res. 2012;14(6):896–904. PubMedCrossRef
Database ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT01878331
Bassetti M, Kaufmann R, Salvi GE, Sculean A, Bassetti R. Soft tissue grafting to improve the attached mucosa at dental implants: A review of the literature and proposal of a decision tree. Quintessence Int. 2015;46(6):499–510. PubMed
Schimmel M, Loup A, Duvernay E, Gaydarov N, Müller F. The effect of lower denture abstention on masseter muscle thickness in a 97 year-old patient: a case report. Int J Prosthodont. 2010;23:418–20. PubMed
Zhao L, Lin HC, Lo EC, Wong MC. Clinical and socio-demographic factors influencing the oral health-related quality of life of Chinese elders. Community Dent Health. 2011;28(3):206–10. PubMed
Walton JN, MacEntee MI. Choosing or refusing oral implants: a prospective study of edentulous volunteers for a clinical trial. Int J Prosthodont. 2005;18(6):483–8. PubMed
Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz-Vigon A, Rousseau P, et al. A prospective non-interventional study to evaluate survival and success of reduced diameter implants made from titanium-zirconium alloy. J Oral Implantol. 2014;41((4)):e118–25. PubMed
- Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlled trial
On behalf of the Roxolid Study Group
- BioMed Central
Neu im Fachgebiet Zahnmedizin
Mail Icon II